Skip to main content
. 2018 Aug 23;10:85. doi: 10.1186/s13195-018-0415-6

Fig. 2.

Fig. 2

Ratio of cerebrospinal fluid (CSF) and unbound plasma atabecestat (JNJ-54861911) concentration in Caucasian patients with preclinical Alzheimer’s disease (AD) and patients with mild cognitive impairment (MCI) due to AD (ALZ1005), by dose group